The differential modulation on cytochrome P450 enzymes by garlic components

Food Reviews International

Volumn 26, Issue 4, 2010, Pages 353-363

  Zeng, Tao ^a   Xie, Ke Qin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Anticancer; Chemoprotective; CYP450; Garlic; Xenobiotics

Indexed keywords

ANTICANCER; CHEMOPROTECTIVE; CYP450; GARLIC; XENOBIOTICS;

BIOCHEMISTRY; MODULATION; SULFUR COMPOUNDS;

ENZYMES;

ALLIUM SATIVUM;

EID: 77957699362     PISSN: 87559129     EISSN: 15256103     Source Type: Journal    
DOI: 10.1080/87559129.2010.496023     Document Type: Article

References (82)

1. Agarwal, K.C. Therapeutic actions of garlic constituents. Med. Res. Rev. 1996, 16 (1), 111-124.
2. Amagase, H.; Petesch, B.L.; Matsuura, H.; Kasuga, S.; Itakura, Y. Intake of garlic and its bioactive components. Journal of Nutrition 2001, 131 (955s-962s).
3. Banerjee, S.K.; Mukherjee, P.K.; Maulik, S.K. Garlic as an antioxidant: the good, the bad and the ugly. Phytother. Res. 2003, 17 (2), 97-106.
4. Amagase, H. Clarifying he real bioactive constituents of garlic. Journal of Nutrition 2006, 136 (3), 716s-725s.
5. Cederbaum, A.I. CYP2E1-biochemical and toxicological aspects and role in alcohol-induced liver injury. Mt Sinai J Med. 2006, 73 (4), 657-672.
6. Gonzalez, F.J. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat. Res. 2005, 569 (1-2), 101-110.
7. Chung, I.; Kwon, S.H.; Shim, S.T.; Kyung, K.H. Synergistic antiyeast activity of garlic oil and allyl alcohol derived from alliin in garlic. Journal of Food Science 2007, 72 (9), M437-M440.
8. Borek, C. Antioxidant health effects of aged garlic extract. J. Nutr. 2001, 131 (3s), 1010S-1015S.
9. Chang, H.P.; Chen, Y.H. Differential effects of organosulfur compounds from garlic oil on nitric oxide and prostaglandin E2 in stimulated macrophages. Nutrition 2005, 21 (4), 530-536.
10. Koop, D.R.; Morgan, E.T.; Tarr, G.E.; Coon, M.J. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits. J. Biol. Chem. 1982, 257 (14), 8472-8480.
11. Puccini, P.; Menicagli, S.; Longo, V.; Santucci, A.; Gervasi, P.G. Purification and characterization of an acetone-inducible cytochrome P-450 from hamster liver microsomes. Biochem. J. 1992, 287 (Pt 3)(863-870).
12. Ryan, D.E.; Ramanathan, L.; Iida, S.; Thomas, P.E.; Haniu, M.; Shively, J.E.; Lieber, C.S.; Levin, W. Characterization of a major form of rat hepatic microsomal cytochrome P-450 induced by isoniazid. J. Biol. Chem. 1985, 260 (10), 6385-6393.
13. Wrighton, S.A.; Thomas, P.E.; Ryan, D.E.; Levin, W. Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj. Arch. Biochem. Biophys. 1987, 258 (1), 292-297.
14. Koop, D.R. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 1992, 6 (2), 724-730.
15. Yang, C.S.; Brady, J.F.; Hong, J.Y. Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity. FASEB J. 1992, 6 (2), 737-744.
16. Fukao, T.; Hosono, T.; Misawa, S.; Seki, T.; Ariga, T. The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride. Food Chem. Toxicol. 2004, 42 (5), 743-749.
17. Patten, C.J.; Thomas, P.E.; Guy, R.L.; Lee, M.; Gonzalez, F.J.; Guengerich, F.P.; Yang, C.S. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 1993, 6 (4), 511-518.
18. Zaher, H.; Buters, J.T.; Ward, J.M.; Bruno, M.K.; Lucas, A.M.; Stern, S.T.; Cohen, S.D.; Gonzalez, F.J. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol. Appl. Pharmacol. 1998, 152 (1), 193-199.
19. Tonge, R.P.; Kelly, E.J.; Bruschi, S.A.; Kalhorn, T.; Eaton, D.L.; Nebert, D.W.; Nelson, S.D. Role of CYP1A2 in the hepatotoxicity of acetaminophen: investigations using Cyp1a2 null mice. Toxicol. Appl. Pharmacol. 1998, 153 (1), 102-108.
20. Wang, E.J.; Li, Y.; Lin, M.; Chen, L.; Stein, A.P.; Reuhl, K.R.; Yang, C.S. Protective effects of garlic and related organosulfur compounds on acetaminophen-induced hepatotoxicity in mice. Toxicol. Appl. Pharmacol. 1996, 136 (1), 146-154.
21. Hu, J.J.; Yoo, J.S.; Lin, M.; Wang, E.J.; Yang, C.S. Protective effects of diallyl sulfide on acetaminophen-induced toxicities. Food Chem. Toxicol. 1996, 34 (10), 963-969.
22. Lin, M. C.; Wang, E. J.; Patten, C.; Lee, M. J.; Xiao, F.; Reuhl, K. R.; Yang, C. S. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice. J. Biochem. Toxicol. 1996, 11 (1), 11-20.
23. Sumioka, I.; Matsura, T.; Kasuga, S.; Itakura, Y.; Yamada, K. Mechanisms of protection by S-allylmercaptocysteine against acetaminophen-induced liver injury in mice. Jpn. J. Pharmacol. 1998, 78 (2), 199-207.
24. Sumioka, I.; Matsura, T.; Yamada, K. Therapeutic effect of S-allylmercaptocysteine on acetaminophen-induced liver injury in mice. Eur. J. Pharmacol. 2001, 433 (2-3), 177-185.
25. Sheweita, S.A.; El-Gabar, M.A.; Bastawy, M. Carbon tetrachloride changes the activity of cytochrome P450 system in the liver of male rats: role of antioxidants. Toxicology 2001, 169 (2), 83-92.
26. Augusti, K.T.; Anuradha Prabha, S.P.; Smitha, K.B.; Sudheesh, M.; George, A.; Joseph, M.C. contributor Nutraceutical effects of garlic oil, its nonpolar fraction and a Ficus flavonoid as compared to vitamin E in CCl4 induced liver damage in rats. Indian J. Exp. Biol. 2005, 43 (5), 437-444.
27. Kagawa, K.; Matsutaka, H.; Yamaguchi, Y.; Fukuhama, C. Garlic extract inhibits the enhanced peroxidation and production of lipids in carbon tetrachloride-induced liver injury. Jpn. J. Pharmacol. 1986, 42 (1), 19-26.
28. Kodai, S.; Takemura, S.; Minamiyama, Y.; Hai, S.; Yamamoto, S.; Kubo, S.; Yoshida, Y.; Niki, E.; Okada, S.; Hirohashi, K.; Suehiro, S. S-allyl cysteine prevents CCl(4)-induced acute liver injury in rats. Free Radic. Res. 2007, 41 (4), 489-497.
29. Lieber, C.S. Metabolism of alcohol. Clin. Liver Dis. 2005, 9 (1), 1-35.
30. Wu, D.; Cederbaum, A.I. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicol. Appl. Pharmacol. 2005, 207 (2 Suppl), 70-76.
31. Shimada, M.; Liu, L.; Nussler, N.; Jonas, S.; Langrehr, J.M.; Ogawa, T.; Kaminishi, M.; Neuhaus, P.; Nussler, A.K. Human hepatocytes are protected from ethanol-induced cytotoxicity by DADS via CYP2E1 inhibition. Toxicol. Lett. 2006, 163 (3), 242-249.
32. Ki, S.H.; Choi, J.H.; Kim, C.W.; Kim, S.G. Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity. Chem. Biol. Interact. 2007, 169 (2), 80-90.
33. Zeng, T.; Guo, F.F.; Zhang, C.L.; Zhao, S.; Dou, D.D.; Gao, X.C.; Xie, K.Q. The anti-fatty liver effects of garlic oil on acute ethanol-exposed mice. Chem. Biol. Interact. 2008, 176 (2-3), 234-242.
34. Zeng, T.; Zhang, C.L.; Pan, G.B.; Zhao, S.; Dou, D.D.; Xin, X.; Xie, K.Q. The protective effects of garlic oil on acute ethanol-induced oxidative stress in the liver of mice. Journal of the Science of Food and Agriculture 2008, 88 (13), 2238-2243.
35. Zeng, T.; Zhang, C.L.; Zhu, Z.P.; Yu, L.H.; Zhao, X.L.; Xie, K.Q. Diallyl trisulfide (DATS) effectively attenuated oxidative stress-mediated liver injury and hepatic mitochondrial dysfunction in acute ethanol-exposed mice. Toxicology. 2008, 252 (1-3), 86-91.
36. Bardag-Gorce, F.; French, B.A.; Nan, L.; Song, H.; Nguyen, S.K.; Yong, H.; Dede, J.; French, S.W. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp. Mol. Pathol. 2006, 81 (3), 191-201.
37. Liu, L. G.; Yan, H.; Yao, P.; Zhang, W.; Zou, L.J.; Song, F.F.; Li, K.; Sun, X.F. CYP2E1-dependent hepatotoxicity and oxidative damage after ethanol administration in human primary hepatocytes. World. J. Gastroenterol. 2005, 11 (29), 4530-4535.
38. McDonough, K.H. Antioxidant nutrients and alcohol. Toxicology 2003, 189 (1-2), 89-97.
39. Morimoto, M.; Hagbjork, A.L.; Wan, Y.J.; Fu, P.C.; Clot, P.; Albano, E.; Ingelman-Sundberg, M.; French, S.W. Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 1995, 21 (6), 1610-1617.
40. Danielson, P.B. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr. Drug Metab. 2002, 3 (6), 561-597.
41. Pan, J.; Hong, J.Y.; Ma, B.L.; Ning, S.M.; Paranawithana, S.R.; Yang, C.S. Transcriptional activation of cytochrome P450 2B1/2 genes in rat liver by diallyl sulfide, a compound derived from garlic. Arch. Biochem. Biophys. 1993, 302 (2), 337-342.
42. Chen, H.W.; Yang, J.J.; Tsai, C.W.; Wu, J.J.; Sheen, L.Y.; Ou, C.C.; Lii, C.K. Dietary fat and garlic oil independently regulate hepatic cytochrome p(450) 2B1 and the placental form of glutathione S-transferase expression in rats. J. Nutr. 2001, 131 (5), 1438-1443.
43. Wu, C.C.; Sheen, L.Y.; Chen, H.W.; Kuo, W.W.; Tsai, S.J.; Lii, C.K. Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats. J. Agric. Food Chem. 2002, 50 (2), 378-383.
44. Lii, C.K.; Tsai, C.W.; Wu, C.C. Garlic allyl sulfides display differential modulation of rat cytochrome P450 2B1 and the placental form glutathione S-transferase in various organs. J. Agric. Food Chem. 2006, 54 (14), 5191-5196.
45. Brady, J.F.; Ishizaki, H.; Fukuto, J.M.; Lin, M.C.; Fadel, A.; Gapac, J.M.; Yang, C.S. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem. Res. Toxicol. 1991, 4 (6), 642-647.
46. Yang, C.S.; Smith, T.J.; Hong, J.Y. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res. 1994, 54 (7 Suppl.), 1982s-1986s.
47. Siess, M.H.; Le Bon, A.M.; Canivenc-Lavier, M.C.; Suschetet, M. Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides. Cancer Lett. 1997, 120 (2), 195-201.
48. Guyonnet, D.; Belloir, C.; Suschetet, M.; Siess, M.H.; Le Bon, A.M. Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation. Mutat Res. 2000, 466 (1), 17-26.
49. Davenport, D.M.; Wargovich, M.J. Modulation of cytochrome P450 enzymes by organosulfur compounds from garlic. Food Chem. Toxicol. 2005, 43 (12), 1753-1762.
50. Piscitelli, S.C.; Burstein, A.H.; Welden, N.; Gallicano, K.D.; Falloon, J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin. Infect. Dis. 2002, 34 (2), 234-238.
51. Markowitz, J.S.; Devane, C.L.; Chavin, K.D.; Taylor, R.M.; Ruan, Y.; Donovan, J.L. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers. Clin. Pharmacol. Ther. 2003, 74 (2), 170-177.
52. Greenblatt, D.J.; Leigh-Pemberton, R.A.; von Moltke, L.L. In vitro interactions of water-soluble garlic components with human cytochromes p450. J. Nutr. 2006, 136 (3 Suppl.), 806S-809S.
53. Liu, C.T.; Chen, H.W.; Sheen, L.Y.; Kung, Y.L.; Chen, P.C.H.; Lii, C.K. Effect of garlic oil on hepatic arachidonic acid content and immune response in rats. Journal of Agricultural and Food Chemistry 1998, 46 (11), 4642-4647.
54. Guengerich, F.P. Reactions and significance of cytochrome P-450 enzymes. J. Biol. Chem. 1991, 266 (16), 10019-10022.
55. Guengerich, F.P.; Shimada, T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 1991, 4 (4), 391-407.
56. van Schaik, R.H. CYP450 pharmacogenetics for personalizing cancer therapy. Drug Resist. Update 2008, 11 (3), 77-98.
57. Wrighton, S.A.; Schuetz, E.G.; Thummel, K.E.; Shen, D.D.; Korzekwa, K.R.; Watkins, P.B. The human CYP3A subfamily: practical considerations. Drug Metab. Rev. 2000, 32 (3-4), 339-361.
58. Huber, W.W.; McDaniel, L.P.; Kaderlik, K.R.; Teitel, C.H.; Lang, N.P.; Kadlubar, F.F. Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP) in the rat. Mutat. Res. 1997, 376 (1-2), 115-122.
59. Mori, H.; Sugie, S.; Rahman, W.; Suzui, N. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo [4, 5-b] pyridine-induced mammary carcinogenesis in rats. Cancer Lett. 1999, 143 (2), 195-198.
60. Le Bon, A.M.; Vernevaut, M.F.; Guenot, L.; Kahane, R.; Auger, J.; Arnault, I.; Haffner, T.; Siess, M.H. Effects of garlic powders with varying alliin contents on hepatic drug metabolizing enzymes in rats. J. Agric. Food Chem. 2003, 51 (26), 7617-7623.
61. Block, E. The chemistry of garlic and onions. Sci. Am. 1985, 252 (3), 114-119.
62. Hartwell, J.L. Plants used against cancer. A survey. Lloydia 1971, 34 (4), 386-425.
63. Fleischauer, A.T.; Arab, L. Garlic and cancer: a critical review of the epidemiologic literature. J. Nutr. 2001, 131 (3s), 1032S-1040S.
64. Brady, J.F.; Li, D.C.; Ishizaki, H.; Yang, C.S. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities. Cancer Res. 1988, 48 (21), 5937-5940.
65. Katsuki, T.; Hirata, K.; Ishikawa, H.; Matsuura, N.; Sumi, S.; Itoh, H. Aged garlic extract has chemopreventative effects on 1,2-dimethylhydrazine-induced colon tumors in rats. J Nutr. 2006, 136 (3 Suppl.), 847S-851S.
66. Nagabhushan, M.; Line, D.; Polverini, P.J.; Solt, D.B. Anticarcinogenic action of diallyl sulfide in hamster buccal pouch and forestomach. Cancer Lett. 1992, 66 (3), 207-216.
67. Srivastava, S.K.; Hu, X.; Xia, H.; Zaren, H.A.; Chatterjee, M.L.; Agarwal, R.; Singh, S.V. Mechanism of differential efficacy of garlic organosulfides in preventing benzo(a)pyreneinduced cancer in mice. Cancer Lett. 1997, 118 (1), 61-67.
68. Sundaresan, S.; Subramanian, P. S-allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis. Pol. J. Pharmacol. 2003, 55 (1), 37-42.
69. Milner, J.A. Preclinical perspectives on garlic and cancer. J. Nutr. 2006, 136 (3 Suppl), 827S-831S.
70. Thomson, M.; Ali, M. Garlic [Allium sativum]: a review of its potential use as an anti-cancer agent. Curr. Cancer Drug Targets 2003, 3 (1), 67-81.
71. Milner, J.A. Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv. Exp. Med. Biol. 2001, 492, 69-81.
72. Nagini, S. Cancer chemoprevention by garlic and its organosulfur compounds-panacea or promise? Anticancer Agents Med. Chem. 2008, 8 (3), 313-321
73. Munday, R.; Munday, C.M. Low doses of diallyl disulfide, a compound derived from garlic, increase tissue activities of quinone reductase and glutathione transferase in the gastrointestinal tract of the rat. Nutr. Cancer. 1999, 34 (1), 42-48.
74. Talalay, P. Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Adv Enzyme Regul. 1989, 28, 237-250.
75. Bhuvaneswari, V.; Abraham, S.K.; Nagini, S. Combinatorial antigenotoxic and anticarcinogenic effects of tomato and garlic through modulation of xenobiotic-metabolizing enzymes during hamster buccal pouch carcinogenesis. Nutrition 2005, 21 (6), 726-731.
76. Novak, R.F.; Woodcroft, K.J. The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch. Pharm. Res. 2000, 23 (4), 267-282.
77. Jin, L.; Baillie, T.A. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats. Chem. Res. Toxicol. 1997, 10 (3), 318-327.
78. Forkert, P.G.; Premdas, P.D.; Bowers, R.J. Epoxide formation from diallyl sulfone is associated with CYP2E1 inactivation in murine and human lungs. Am. J. Respir. Cell Mol. Biol. 2000, 23 (5), 687-695.
79. Premdas, P.D.; Bowers, R.J.; Forkert, P.G. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone. J Pharmacol. Exp. Ther. 2000, 293 (3), 1112-1120.
80. Lewis, D.F.; Bird, M.G.; Parke, D.V. Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity. Toxicology 1997, 118 (2-3), 93-113.
81. Egen-Schwind, C.; Eckard, R.; Kemper, F.H. Metabolism of garlic constituents in the isolated perfused rat liver. Planta Med. 1992, 58 (4), 301-305.
82. Kwak, M.K.; Kim, S.G.; Kim, N.D. Effects of garlic oil on rat hepatic P4502E1 expression. Xenobiotica 1995, 25 (10), 1021-1029.